Literature DB >> 30084948

Members of the GalNAc-T family of enzymes utilize distinct Golgi localization mechanisms.

Jessica L Becker1, Duy T Tran1, Lawrence A Tabak1.   

Abstract

Mucin-type O-glycosylation is an evolutionarily conserved and essential post-translational protein modification that is initiated in the Golgi apparatus by a family of enzymes known as the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). GalNAc-Ts are type II membrane proteins which contain short N-terminal tails located in the cytoplasm, a transmembrane domain that crosses the Golgi membrane, to which is connected a stem region that tethers the C-terminal catalytic and lectin domains that reside in the Golgi lumen. Although mucin-type O-glycans have been shown to play critical roles in numerous biological processes, little is known about how the GalNAc-Ts are targeted to their site of action within the Golgi complex. Here, we investigate the essential protein domains required for Golgi localization of four representative members of the GalNAc-T family of enzymes. We find that GalNAc-T1 and -T2 require their cytoplasmic tail and transmembrane domains for proper Golgi localization, while GalNAc-T10 requires its transmembrane and luminal stem domains. GalNAc-T7 can use either its cytoplasmic tail or its luminal stem, in combination with its transmembrane domain, to localize to the Golgi. We determined that a single glutamic acid in the GalNAc-T10 cytoplasmic tail inhibits its ability to localize to the Golgi via a cytoplasmic tail-dependent mechanism. We therefore demonstrate that despite their similarity, different members of this enzyme family are directed to the Golgi by more than one set of targeting signals.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30084948      PMCID: PMC6192461          DOI: 10.1093/glycob/cwy071

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  38 in total

1.  The transmembrane domain of N-glucosaminyltransferase I contains a Golgi retention signal.

Authors:  B L Tang; S H Wong; S H Low; W Hong
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

2.  Cytoplasmic tails of SialT2 and GalNAcT impose their respective proximal and distal Golgi localization.

Authors:  Andrea S Uliana; Claudio G Giraudo; Hugo J F Maccioni
Journal:  Traffic       Date:  2006-05       Impact factor: 6.215

3.  Golgi retention of a trans-Golgi membrane protein, galactosyltransferase, requires cysteine and histidine residues within the membrane-anchoring domain.

Authors:  D Aoki; N Lee; N Yamaguchi; C Dubois; M N Fukuda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

4.  UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: completion of the family tree.

Authors:  Jayalakshmi Raman; Yu Guan; Cynthia L Perrine; Thomas A Gerken; Lawrence A Tabak
Journal:  Glycobiology       Date:  2011-12-20       Impact factor: 4.313

Review 5.  Recent insights into the biological roles of mucin-type O-glycosylation.

Authors:  E Tian; Kelly G Ten Hagen
Journal:  Glycoconj J       Date:  2008-08-10       Impact factor: 2.916

6.  The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.

Authors:  Thomas A Gerken; Leslie Revoredo; Joseph J C Thome; Lawrence A Tabak; Malene Bech Vester-Christensen; Henrik Clausen; Gagandeep K Gahlay; Donald L Jarvis; Roy W Johnson; Heather A Moniz; Kelley Moremen
Journal:  J Biol Chem       Date:  2013-05-20       Impact factor: 5.157

7.  Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase isoforms in murine tissues determined by real-time PCR: a new view of a large family.

Authors:  William W Young; Dana R Holcomb; Kelly G Ten Hagen; Lawrence A Tabak
Journal:  Glycobiology       Date:  2003-03-19       Impact factor: 4.313

8.  An investigation of the role of transmembrane domains in Golgi protein retention.

Authors:  S Munro
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

9.  Characterization and expression analysis of Galnts in developing Strongylocentrotus purpuratus embryos.

Authors:  Amber L Famiglietti; Zheng Wei; Thomas M Beres; Adina L Milac; Duy T Tran; Divya Patel; Robert C Angerer; Lynne M Angerer; Lawrence A Tabak
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

10.  Kin recognition between medial Golgi enzymes in HeLa cells.

Authors:  T Nilsson; M H Hoe; P Slusarewicz; C Rabouille; R Watson; F Hunte; G Watzele; E G Berger; G Warren
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598

View more
  5 in total

Review 1.  Polypeptide N-acetylgalactosamine transferase 3: a post-translational writer on human health.

Authors:  Yohana Camila Garay; Romina Beatriz Cejas; Virginia Lorenz; Natacha Zlocowski; Pedro Parodi; Franco Alejandro Ferrero; Genaro Angeloni; Valentina Alfonso García; Victor German Sendra; Ricardo Dante Lardone; Fernando José Irazoqui
Journal:  J Mol Med (Berl)       Date:  2022-09-02       Impact factor: 5.606

2.  Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in Colorectal Cancer.

Authors:  Makiko Ogawa; Atsushi Tanaka; Kei Namba; Jinru Shia; Julia Y Wang; Michael H Roehrl
Journal:  Front Oncol       Date:  2022-05-27       Impact factor: 5.738

Review 3.  Critical Determinants in ER-Golgi Trafficking of Enzymes Involved in Glycosylation.

Authors:  Ning Zhang; Olga A Zabotina
Journal:  Plants (Basel)       Date:  2022-02-04

4.  Legionella pneumophila Infection of Human Macrophages Retains Golgi Structure but Reduces O-Glycans.

Authors:  Yanlin Fu; Vinitha Macwan; Rebecca Emily-Sue Heineman; Mauricio R Terebiznik; Rene E Harrison
Journal:  Pathogens       Date:  2022-08-12

Review 5.  The Role of APP O-Glycosylation in Alzheimer's Disease.

Authors:  Keiko Akasaka-Manya; Hiroshi Manya
Journal:  Biomolecules       Date:  2020-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.